Lv31
250 积分 2026-05-20 加入
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
17天前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
5个月前
已完结
SnapShot: The hallmarks of cancer treatment
5个月前
已完结
皖公网安备34019202002308
